Pharmaceuticals and Medical Devices Agency (PMDA) has succeeded in shortening the review period for medical products to the world's top standard through its 1st and 2nd Mid-term Plan Periods (FY 2004 ...
PMDA’s global inspection activities bounced back in 2023 after the pandemic hindered assessments of overseas sites in 2020, 2021, and, to a lesser extent, 2023. The agency resumed inspections in China ...
Japan@s Pharmaceuticals and Medical Devices Agency (PMDA) has published principles for evaluating COVID-19 vaccines. The principles echo guidelines published in other parts of the world, for example ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback